Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalBlood
Year 2013

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • RE-COVER I [Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism] (15 documents)
  • RE-COVER II [Phase III Study Testing Efficacy and Safety of Oral Dabigatran Etexilate versus Warfarin for 6 Month Treatment for Acute Symptomatic Venous Thromboembolism (VTE)] (12 documents)
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 014823ec650603d49a188961013f98f04a3a2ad4
First added on: May 17, 2016